Correlation Between Forian and Accolade
Can any of the company-specific risk be diversified away by investing in both Forian and Accolade at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Forian and Accolade into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Forian Inc and Accolade, you can compare the effects of market volatilities on Forian and Accolade and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Forian with a short position of Accolade. Check out your portfolio center. Please also check ongoing floating volatility patterns of Forian and Accolade.
Diversification Opportunities for Forian and Accolade
Very poor diversification
The 3 months correlation between Forian and Accolade is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Forian Inc and Accolade in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Accolade and Forian is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Forian Inc are associated (or correlated) with Accolade. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Accolade has no effect on the direction of Forian i.e., Forian and Accolade go up and down completely randomly.
Pair Corralation between Forian and Accolade
Given the investment horizon of 90 days Forian is expected to generate 4.45 times less return on investment than Accolade. But when comparing it to its historical volatility, Forian Inc is 1.25 times less risky than Accolade. It trades about 0.06 of its potential returns per unit of risk. Accolade is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 330.00 in Accolade on August 30, 2024 and sell it today you would earn a total of 45.00 from holding Accolade or generate 13.64% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 95.65% |
Values | Daily Returns |
Forian Inc vs. Accolade
Performance |
Timeline |
Forian Inc |
Accolade |
Forian and Accolade Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Forian and Accolade
The main advantage of trading using opposite Forian and Accolade positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Forian position performs unexpectedly, Accolade can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Accolade will offset losses from the drop in Accolade's long position.Forian vs. HealthStream | Forian vs. National Research Corp | Forian vs. HealthEquity | Forian vs. Health Catalyst |
Accolade vs. Privia Health Group | Accolade vs. HealthStream | Accolade vs. National Research Corp | Accolade vs. Health Catalyst |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |